| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0005 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0005 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0006 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.17 | 0.0006 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0007 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0008 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.16 | 0.0009 |